In addition, ILF2 expression (p = 0.022), depth of invasion (p = 0.007), TNM stage (p = 0.005), CA19-9 (p = 0.004), and CA125 (p = 0.001) were independent prognostic factors for OS of GC patients (Table 2). This evidence concerns the gene ILF2 and gastric cancer.